Username Password
S&P 500: 1,351.68 Change: +0.14%

GERON CP (GERN)

Overview
Price 2.05
Price Change Today -$0.02 (-0.97%)
P&P rating Rating: 3
Zacks Rank 3 - HOLD
Open Price $2.09
Previous Close $2.07
Daily Range $2.04 - $2.09
52-Week Range $1.35 - $5.24
Volume 463,175
chart
Geron Corporation is a scientific research company that is developing techniques for the health services industry. Their research is currently divided in three different areas. First, they are looking into telomeres and telomerase and their roles in cellular aging and cancer. Second, they are looking pluripotent stem cells as a potential source for the manufacturing of replacement cells and tissues. Lastly, the company is researching nuclear transfer as a potential mechanism for generating genetically matched cells and tissues.
Other Resources for GERN
zacks.com
Commentary
Zacks Blog: Narrower Loss at Geron
November 7, 2011
Zacks Blog: Geron Loss In-Line with Estimates
August 2, 2011
Zacks Blog: Analyst Interview - International Stem Cell
July 27, 2011
Zacks Blog: Analyst Interview - International Stem Cell
July 27, 2011
Zacks Blog: Geron Posts Wider Loss
May 2, 2011
Geron Corporation is a scientific research company that is developing techniques for the health services industry. Their research is currently divided in three different areas. First, they are looking into telomeres and telomerase and their roles in cellular aging and cancer. Second, they are looking pluripotent stem cells as a potential source for the manufacturing of replacement cells and tissues. Lastly, the company is researching nuclear transfer as a potential mechanism for generating genetically matched cells and tissues.
 
Brokerage Analyst Recommendations
6 Brokerage Firms Covering GERN
 
  
Strong Buy
2
Buy
0
Hold
4
Sell
0
Strong Sell
0
Average Broker Recommendation (ABR): 2.33
 
GERN Ratings:BUY  SELL  HOLD
GERN Consensus Forecasts
Rate this Stock!
You haven't rated this stock yet!

What The Community Thinks

Total Players

35 Buy
1 Sell
 
Top Buy Analysis
BUY: GERN Rating: 3
Company: GERON CORPORATION
Points: -85.74
Start Price: $5.69
Start Date: 12/02/2009 5:02 PM
Eversar
Eversar
P&P Score: 95.47
Recs:
Unusually high call volume at $7.5

Comments: 0 | Comment


Top Sell Analysis
SELL: GERN Rating: 3
Company: GERON CORPORATION
Points: 133.72
Start Price: $7.84
Start Date: 01/29/2009 10:34 PM
gargoyleinvestor
gargoyleinvestor
P&P Score: 97.00
Recs:
Pump and dump. This stock does this everytime there's a Democrat whispering of stem cell research. Valuation is ridiculous as is stock. SHORT GERN

Comments: 0 | Comment

Blog Posts
User User Score Date Title Comments Last Comment
Zacks_Analysts
0.00 11/17/11 Geron to Exit Stem Cell Therapy - Analyst Blog 0
Zacks_Analysts
0.00 11/07/11 Narrower Loss at Geron - Analyst Blog 0
Zacks_Analysts
0.00 07/27/11 Analyst Interview - International Stem Cell - Analyst Blog 0
Zacks_Analysts
0.00 05/02/11 Geron Posts Wider Loss - Analyst Blog 0
Zacks_Analysts
0.00 02/28/11 Wider Q4 Loss at Geron - Analyst Blog 0
Zacks_Analysts
0.00 12/09/10 Cephalon in Stem Cell Deal - Analyst Blog 0
Zacks_Analysts
0.00 12/07/10 Geron's Pipeline Progresses - Analyst Blog 0
Zacks_Analysts
0.00 11/02/10 Geron Misses Zacks Ests. - Analyst Blog 0
Zacks_Analysts
0.00 10/12/10 Geron's Pipeline Progresses - Analyst Blog 0
Zacks_Analysts
0.00 08/03/10 Geron Posts Narrower Loss - Analyst Blog 0
Pages: [ 1 ]  2  >>
Commentary
BUY: GERON CORPORATION (GERN) Rating: 3
Start Price: $2.58
Points: -29.18
Created: 10/26/2011
with fda approval, hopefully soon..this stock will take off..

Comments: 0 | Comment

Recs:
 
BUY: GERON CORPORATION (GERN) Rating: 3
Start Price: $5.14
Points: -67.76
Created: 12/21/2010
Stem cells treatments should become a large part of our medical future. This stock was recently hit hard on a public offering. I see that as a buying opportunity.

Comments: 0 | Comment

Recs:
 
BUY: GERON CORPORATION (GERN) Rating: 3
Start Price: $5.22
Points: -80.80
Created: 09/23/2010
cancer drug developer

Comments: 0 | Comment

Recs:
 
BUY: GERON CORPORATION (GERN) Rating: 3
Start Price: $5.55
Points: -84.19
Created: 01/02/2010
going up

Comments: 0 | Comment

Recs:
 
BUY: GERON CORPORATION (GERN) Rating: 3
Start Price: $5.69
Points: -85.74
Created: 12/02/2009
Unusually high call volume at $7.5

Comments: 0 | Comment

Recs:
 
SELL: GERON CORPORATION (GERN) Rating: 3
Start Price: $7.84
Points: +133.72
Created: 01/29/2009
Pump and dump. This stock does this everytime there's a Democrat whispering of stem cell research. Valuation is ridiculous as is stock. SHORT GERN

Comments: 0 | Comment

Recs:
 
BUY: GERON CORPORATION (GERN) Rating: 3
Start Price: $7.24
Points: -131.44
Created: 01/27/2009
Obama has opened the flood gates to stem cell research. Any good news and this one will take off like a rocket.

Comments: 1 | Comment

Recs:
 
BUY: GERON CORPORATION (GERN) Rating: 3
Start Price: $2.17
Points: -17.02
Created: 10/19/2011
buy

Comments: 0 | Comment

Recs:
 
BUY: GERON CORPORATION (GERN) Rating: 3
Start Price: $7.48
Points: -64.60
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
BUY: GERON CORPORATION (GERN) Rating: 3
Start Price: $6.77
Points: -61.72
Created: 01/01/2008

Comments: 0 | Comment

MSK MSK
Recs:
 
Pages: [ 1 ]  2   3   4  >>
Picks
Username P&P Score Call Time Frame Start Date Start Price Today (change) Stock Gain S&P Gain Points Analysis
gilzy 2.29 BUY One to Three Months 10/26/2011 $2.58 $2.06
(-0.48%)
-20.35% +8.83% -29.18 view
rtezanos 0.24 BUY One to Three Months 10/19/2011 $2.17 $2.06
(-0.48%)
-5.30% +11.72% -17.02 view
buckeye33492 0.99 BUY Three Plus Years 12/21/2010 $5.14 $2.06
(-0.48%)
-60.02% +7.74% -67.76 view
scubadoc 0.70 BUY Six Months to a Year 09/23/2010 $5.22 $2.06
(-0.48%)
-60.63% +20.17% -80.80 view
huyducle 1.69 BUY Week or Less 01/02/2010 $5.55 $2.06
(-0.48%)
-62.97% +21.22% -84.19 view
Eversar 95.47 BUY Week to a Month 12/02/2009 $5.69 $2.06
(-0.48%)
-63.88% +21.86% -85.74 view
gargoyleinvestor 97.00 SELL Week to a Month 01/29/2009 $7.84 $2.06
(-0.48%)
-73.79% +59.94% +133.72 view
OnIslandTrader 0.28 BUY One to Three Years 01/27/2009 $7.24 $2.06
(-0.48%)
-71.62% +59.83% -131.44 view
cuzntex 78.35 BUY Six Months to a Year 01/01/2008 $7.48 $2.06
(-0.48%)
-72.53% -7.92% -64.60
MSK 53.49 BUY Six Months to a Year 01/01/2008 $6.77 $2.06
(-0.48%)
-69.65% -7.92% -61.72
Pages: [ 1 ]  2   3   4  >>
Sponsored Links